合肥生物医药产业跑出“加速度”

Core Viewpoint - The article highlights the advancements in the biomedical industry in Hefei, particularly focusing on innovations in medical devices and the supportive ecosystem for companies in this sector. Group 1: Innovations in Medical Technology - The spinal surgery robot developed by Meiya Optoelectronics assists in minimally invasive surgeries, marking a new phase in orthopedic procedures [1] - Hefei has seen multiple innovations in the biomedical field, including the development of an injectable trastuzumab by Anhui Anke Bioengineering and a fully digital PET/CT device by Hefei Ruishi Digital Technology [1][3] Group 2: Importance of Testing and Validation - The establishment of the Hefei Medical Device Testing Center significantly reduces product validation cycles and operational costs for local medical device companies [2] - The center utilizes high-precision laser scanning technology to provide accurate 3D information for medical device firms [1] Group 3: Financial Support and Policy Framework - Hefei has created a dual support system of policies and capital to assist biomedical companies in expanding financing channels [4] - The city has allocated over 100 million yuan annually for two consecutive years to support the development of the biomedical industry, particularly in new drug research and local transformation of medical devices [5] - A 5 billion yuan special direct investment fund has been established to support the biomedical industry, creating a comprehensive funding system from seed to industrial development [5] Group 4: Industry Growth and Ecosystem - Hefei's biomedical industry has attracted over a thousand companies, generating revenues exceeding 100 billion yuan, and is working towards building a top-tier biomedical ecosystem in China [5]